Subcutaneous rituximab for autoimmune bullous diseases.

C Riquelme-Mc Loughlin Pilar Iranzo

Published in: The British journal of dermatology (2021)

Keyphrases

diffuse large b cell lymphoma
multiple sclerosis
chronic lymphocytic leukemia
hodgkin lymphoma
drug induced